BACKGROUND: Early treatment with valproic acid (VPA) has demonstrated benefit in preclinical models of traumatic brain injury, including smaller brain lesion size, decreased edema, reduced neurologic disability, and faster recovery. Mechanisms underlying these favorable outcomes are not fully understood. We hypothesized that VPA treatment would upregulate genes involved in cell survival and proliferation and downregulate those associated with cell death and the inflammatory response. METHODS: Ten female swine were subjected to a protocol of traumatic brain injury and hemorrhagic shock. They were assigned to two groups (n = 5): normal saline (NS; 3× volume of shed blood), or NS + VPA (150 mg/kg). Following 6 hours of observation, brain tissue was harvested to evaluate lesion size and edema. Brain tissue was processed for RNA sequencing. Gene set enrichment and pathway analysis was performed to determine the differential gene expression patterns following injury. RESULTS: Animals treated with VPA were noted to have a 46% reduction in brain lesion size and a 57% reduction in ipsilateral brain edema. Valproic acid significantly upregulated genes involved in morphology of the nervous system, neuronal development and neuron quantity. The VPA treatment downregulated pathways related to apoptosis, glial cell proliferation, and neuroepithelial cell differentiation. Ingenuity Pathway Analysis identified VPA as the top upstream regulator of activated transcription, supporting it as a direct cause of these transcriptional changes. Master transcriptional regulator NEUROD1 was also significantly upregulated, suggesting that VPA may induce additional transcription factors. CONCLUSION: Administration of VPA attenuated brain lesion size, reduced brain edema, and induced significant changes in the transcriptome of injured brain within 6 hours. Patterns of differential expression were consistent with the proposed neurogenic and prosurvival effects of VPA treatment.
BACKGROUND: Early treatment with valproic acid (VPA) has demonstrated benefit in preclinical models of traumatic brain injury, including smaller brain lesion size, decreased edema, reduced neurologic disability, and faster recovery. Mechanisms underlying these favorable outcomes are not fully understood. We hypothesized that VPA treatment would upregulate genes involved in cell survival and proliferation and downregulate those associated with cell death and the inflammatory response. METHODS: Ten female swine were subjected to a protocol of traumatic brain injury and hemorrhagic shock. They were assigned to two groups (n = 5): normal saline (NS; 3× volume of shed blood), or NS + VPA (150 mg/kg). Following 6 hours of observation, brain tissue was harvested to evaluate lesion size and edema. Brain tissue was processed for RNA sequencing. Gene set enrichment and pathway analysis was performed to determine the differential gene expression patterns following injury. RESULTS: Animals treated with VPA were noted to have a 46% reduction in brain lesion size and a 57% reduction in ipsilateral brain edema. Valproic acid significantly upregulated genes involved in morphology of the nervous system, neuronal development and neuron quantity. The VPA treatment downregulated pathways related to apoptosis, glial cell proliferation, and neuroepithelial cell differentiation. Ingenuity Pathway Analysis identified VPA as the top upstream regulator of activated transcription, supporting it as a direct cause of these transcriptional changes. Master transcriptional regulator NEUROD1 was also significantly upregulated, suggesting that VPA may induce additional transcription factors. CONCLUSION: Administration of VPAattenuated brain lesion size, reduced brain edema, and induced significant changes in the transcriptome of injured brain within 6 hours. Patterns of differential expression were consistent with the proposed neurogenic and prosurvival effects of VPA treatment.
Authors: M Göttlicher; S Minucci; P Zhu; O H Krämer; A Schimpf; S Giavara; J P Sleeman; F Lo Coco; C Nervi; P G Pelicci; T Heinzel Journal: EMBO J Date: 2001-12-17 Impact factor: 11.598
Authors: Ayesha M Imam; Guang Jin; Michael Duggan; Martin Sillesen; John O Hwabejire; Cecilie H Jepsen; Danielle DePeralta; Baoling Liu; Jennifer Lu; Marc A deMoya; Simona Socrate; Hasan B Alam Journal: Surgery Date: 2013-08 Impact factor: 3.982
Authors: Eric E Zhang; Andrew C Liu; Tsuyoshi Hirota; Loren J Miraglia; Genevieve Welch; Pagkapol Y Pongsawakul; Xianzhong Liu; Ann Atwood; Jon W Huss; Jeff Janes; Andrew I Su; John B Hogenesch; Steve A Kay Journal: Cell Date: 2009-09-17 Impact factor: 41.582
Authors: Tom Lin; Hasan B Alam; Huazhen Chen; Joy Britten-Webb; Peter Rhee; John Kirkpatrick; Elena Koustova Journal: Surgery Date: 2006-03 Impact factor: 3.982
Authors: Deborah R Boone; Stacy L Sell; Maria-Adelaide Micci; Jeanna M Crookshanks; Margaret Parsley; Tatsuo Uchida; Donald S Prough; Douglas S DeWitt; Helen L Hellmich Journal: PLoS One Date: 2012-10-03 Impact factor: 3.240
Authors: Gerald A Higgins; Patrick Georgoff; Vahagn Nikolian; Ari Allyn-Feuer; Brian Pauls; Richard Higgins; Brian D Athey; Hasan E Alam Journal: Pharm Res Date: 2017-03-07 Impact factor: 4.200
Authors: Aaron M Williams; Isabel S Dennahy; Umar F Bhatti; Ben E Biesterveld; Nathan J Graham; Yongqing Li; Hasan B Alam Journal: Shock Date: 2019-09 Impact factor: 3.454
Authors: Andrew R Mayer; Andrew B Dodd; Meghan S Vermillion; David D Stephenson; Irshad H Chaudry; Denis E Bragin; Andrew P Gigliotti; Rebecca J Dodd; Benjamin C Wasserott; Priyank Shukla; Rachel Kinsler; Sheila M Alonzo Journal: Neurosci Biobehav Rev Date: 2019-06-27 Impact factor: 8.989
Authors: Ben E Biesterveld; Rachel O'Connell; Michael T Kemp; Glenn K Wakam; Aaron M Williams; Manjunath P Pai; Hasan B Alam Journal: Trauma Surg Acute Care Open Date: 2021-03-17
Authors: Luke Pumiglia; Aaron M Williams; Michael T Kemp; Glenn K Wakam; Hasan B Alam; Ben E Biesterveld Journal: Trauma Surg Acute Care Open Date: 2021-03-24
Authors: Ben E Biesterveld; Luke Pumiglia; Ariella Iancu; Alizeh A Shamshad; Henriette A Remmer; Ali Z Siddiqui; Rachel L O'Connell; Glenn K Wakam; Michael T Kemp; Aaron M Williams; Manjunath P Pai; Hasan B Alam Journal: J Trauma Acute Care Surg Date: 2020-12 Impact factor: 3.697